Orpro Therapeutics

- PRIVATE:ORPROTHERAPEUTICS
  • OrPro Therapeutics develops recombinant thioredoxin for the treatment of cystic fibrosis.
  • Locations

    • San Diego CA
  • Total Funding (USD)

    2.0 million
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.